Myelodysplastic syndrome: an update on diagnosis and therapy (Q37244697)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 2008

edit

Language	Label	Description	Also known as
English	Myelodysplastic syndrome: an update on diagnosis and therapy	scientific article published on September 2008

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18706264

retrieved

19 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Myelodysplastic syndrome: an update on diagnosis and therapy (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18706264

retrieved

19 August 2017

main subject

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

author name string

Ahrin Koppel

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18706264

retrieved

19 August 2017

Gary Schiller

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18706264

retrieved

19 August 2017

publication date

1 September 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18706264

retrieved

19 August 2017

published in

Current Oncology Reports

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18706264

retrieved

19 August 2017

volume

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18706264

retrieved

19 August 2017

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18706264

retrieved

19 August 2017

page(s)

372-378

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18706264

retrieved

19 August 2017

cites work

Proposals for the classification of the myelodysplastic syndromes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11912-008-0058-Z

retrieved

21 January 2018

Rheumatic manifestations of the myelodysplastic syndromes: a comparative study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11912-008-0058-Z

retrieved

21 January 2018

Chronic myelomonocytic leukemia: natural history and prognostic determinants

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11912-008-0058-Z

retrieved

21 January 2018

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The evolution of thalidomide and its IMiD derivatives as anticancer agents

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypermethylation of the p15INK4B gene in myelodysplastic syndromes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune-mediated complications in patients with myelodysplastic syndromes--clinical and cytogenetic features

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytogenetic aspects of adult primary myelodysplastic syndromes: clinical implications

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: clinical results and possible mechanisms of action

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of an international working group to standardize response criteria for myelodysplastic syndromes.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chromosomal alterations associated with evolution from myelodysplastic syndrome to acute myeloid leukemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The 5q- syndrome: a single-institution study of 43 consecutive patients.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors in MDS.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow histology and CD34 immunostaining in the prognostic evaluation of primary myelodysplastic syndromes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decitabine in myelodysplastic syndromes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of low-dose cytosine arabinoside and aggressive chemotherapy in advanced myelodysplastic syndromes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modifying the epigenome as a therapeutic strategy in myelodysplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute febrile neutrophilic dermatosis (Sweet's syndrome) in association with myelodysplastic syndromes: a report of three cases and a review of the literature

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International scoring system for evaluating prognosis in myelodysplastic syndromes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of lenalidomide in myelodysplastic syndromes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statistics

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene silencing in cancer in association with promoter hypermethylation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic value of histology and immunohistochemistry in myelodysplastic syndromes.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

French registry of acute leukemia and myelodysplastic syndromes. Age distribution and hemogram analysis of the 4496 cases recorded during 1982-1983 and classified according to FAB criteria. Groupe Francais de Morphologie Hematologique

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18706264

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11912-008-0058-Z

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18706264

retrieved

19 August 2017

PubMed publication ID

18706264

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18706264

retrieved

19 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37244697&oldid=2200080177"